PureTech Health plc (NASDAQ:PRTC - Get Free Report) was down 4.2% during mid-day trading on Monday . The company traded as low as $17.83 and last traded at $18.20. Approximately 1,376 shares changed hands during mid-day trading, a decline of 71% from the average daily volume of 4,708 shares. The stock had previously closed at $19.00.
PureTech Health Stock Up 3.1%
The stock's fifty day moving average price is $17.22 and its 200-day moving average price is $18.69.
Institutional Trading of PureTech Health
Hedge funds and other institutional investors have recently made changes to their positions in the business. Pentwater Capital Management LP raised its holdings in shares of PureTech Health by 39.2% in the first quarter. Pentwater Capital Management LP now owns 33,560 shares of the company's stock valued at $664,000 after purchasing an additional 9,449 shares during the last quarter. Millennium Management LLC acquired a new stake in shares of PureTech Health in the fourth quarter valued at approximately $823,000. Finally, Birch Hill Investment Advisors LLC acquired a new stake in shares of PureTech Health in the fourth quarter valued at approximately $5,575,000. 0.04% of the stock is currently owned by institutional investors and hedge funds.
About PureTech Health
(
Get Free Report)
PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, which is under Phase 2 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, targeting galectin-9 for treating solid tumors and hematological malignancies.
Featured Articles
Before you consider PureTech Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and PureTech Health wasn't on the list.
While PureTech Health currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
